Abstract
Nerve growth factor (NGF) is involved in a variety of processes involving signalling, such as cell differentiation and survival, growth cessation and apoptosis of neurons1. These events are mediated by NGF as a result of binding to its two cell-surface receptors, TrkA and p75 (ref. 2). TrkA is a receptor with tyrosine kinase activity that forms a high-affinity binding site for NGF3. Of the five domains comprising its extracellular portion, the immunoglobulin-like domain proximal to the membrane (TrkA-d5 domain) is necessary and sufficient for NGF binding4. Here we present the crystal structure of human NGF in complex with human TrkA-d5 at 2.2 Å resolution. The ligand–receptor interface consists of two patches of similar size. One patch involves the central β-sheet that forms the core of the homodimeric NGF molecule and the loops at the carboxy-terminal pole of TrkA-d5. The second patch comprises the amino-terminal residues of NGF, which adopt a helical conformation upon complex formation, packing against the ‘ABED’ sheet of TrkA-d5. The structure is consistent with results from mutagenesis experiments for all neurotrophins, and indicates that the first patch may constitute a conserved binding motif for all family members, whereas the second patch is specific for the interaction between NGF and TrkA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Snider,W. D. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77, 627–638 (1994).
Chao,M. et al. Neurotrophin receptors: mediators of life and death. Brain Res. Rev. 26, 295–301 (1998).
Kaplan,D. R., Hempstead,B. L. Martin-Zanca,D., Chao,M. V. & Parada,L. F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554–558 (1991).
Urfer,R. et al. An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J. 14, 2795–2805 (1995).
Chao,M. V. Neurotrophin receptors: a window into neuronal differentiation. Neuron 9, 583–593 (1992).
Götz,R. et al. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372, 366–269 (1994).
Schneider,R. & Schweiger,M. A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors. Oncogene 6, 1807–1811 (1991).
Peréz,P., Coll,P. M., Hempstead,B. L., Martin-Zanca,D. & Chao,M. V. NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol. Cell. Neurosci. 6, 97–105 (1995).
Ultsch,M. et al. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC. J. Mol. Biol. 290, 149–159 (1999).
McDonald,N. Q. et al. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature 354, 411–414 (1991).
McInnes,C. & Sykes,B. D. Growth factor receptors: structure, mechanism, and drug discovery. Biopolymers 43, 339–366 (1997).
Urfer,R. et al. The binding epitopes of neurotrophin-3 to its receptors trkC and gp75 and the design of a multifunctional human neurotrophin. EMBO J. 13, 5896–5909 (1994).
Urfer,R. et al. High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors. J. Biol. Chem. 273, 5829–5840 (1998).
Ibáñez,C. F., Ebendal,T. & Persson,H. Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J. 10, 2105–2110 (1991).
Kullander,K. & Ebendal,T. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor. J. Neurosci. Res. 39, 195–210 (1994).
Ibáñez,C. F., Ilag,L. L., Murray-Rust,J. & Persson,H. An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. EMBO J. 12, 2281–2293 (1993).
O'Leary,P. D. & Hughes,R. A. Structure-activity relationships of conformationally constrained peptide analogues of loop 2 of brain-derived neurotrophic factor. J. Neurochem. 70, 1712–1721 (1998).
Urfer,R., Tsoulfas,P., O'Connell,L. & Presta,L. G. Specificity determinants in neurotrophin-3 and design of nerve growth factor-based trkC agonists by changing central beta-strand bundle residues to their neurotrophin-3 analogs. Biochemistry 36, 4775–4781 (1997).
Windisch,J. M., Marksteiner,R. & Schneider,R. Nerve growth factor binding site on TrkA mapped to a single 24-amino acid leucine-rich motif. J. Biol. Chem. 270, 28133–28138 (1995).
Windisch,J. M., Marksteiner,R., Lang,M. E., Auer,B. & Schneider,R. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 bind to a single leucine-rich motif of TrkB. Biochemistry 34, 11256–11263 (1995).
Dechant,G., Tsoulfas,P., Parada,L. F. & Barde,Y. A. The neurotrophin receptor p75 binds neurotrophin-3 on sympathetic neurons with high affinity and specificity. J. Neurosci. 17, 5271–5287 (1997).
Ibáñez,C. F. et al. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69, 329–341 (1992).
Ryden,M. & Ibanez,C. F. A second determinant of binding to the p75 neurotrophin receptor revealed by alanine-scanning mutagenesis of a conserved loop in nerve growth factor. J. Biol. Chem. 272, 33085–33091 (1997).
Wiesmann,C. et al. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695–704 (1997).
Sun,P. D. & Davies,D. R. The cystine-knot growth-factor superfamily. Annu. Rev. Biophys. Biomol. Struct. 24, 269–291 (1995).
Otwinowski,Z. & Minor,W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
CCP4. Programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
Jones,T. A., Zhou, J.-Y., Cowan,S. W. & Kjelgaard,M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Brünger,A. T., Kuriyan,J. & Karplus,M. Crystallographic R factor refinement by molecular dynamics. Science 235, 458–460 (1987).
Laskowski,R. A., MacArthur,M. W., Moss,D. S. & Thornton,J. M. Procheck: a program to check to the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283–291 (1993).
Acknowledgements
We thank the following colleagues at Genentech: E. Martin and G. Burton for purified NGF; D. Reilly for fermentation runs; W. Henzel for N-terminal sequencing; J. Bourell for mass spectrometry analysis; H. Christinger for help with data collection; and L. Presta and D. Shelton for helpful discussions. We also thank the staff at SSRL, beam line 9-1, and ALS, beam line 5.2; and D. Dawbarn for sharing data before publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiesmann, C., Ultsch, M., Bass, S. et al. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–188 (1999). https://doi.org/10.1038/43705
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/43705
This article is cited by
-
The role of neurotrophic factors in novel, rapid psychiatric treatments
Neuropsychopharmacology (2024)
-
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects
CNS Drugs (2023)
-
Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson’s
Neurological Sciences (2023)
-
NGF monoclonal antibody DS002 alleviates chemotherapy-induced peripheral neuropathy in rats
Acta Pharmacologica Sinica (2022)
-
Structure of a meiosis-specific complex central to BRCA2 localization at recombination sites
Nature Structural & Molecular Biology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.